Antipsychotic augmentation in the treatment of obsessive-compulsive disorder

Most studies suggest that obsessive-compulsive disorder runs a chronic course. Only 40%–70% of patients respond to first-line treatment with selective serotonin reuptake inhibitors (SSRIs). The most common pharmacological strategy used in clinical practice for partial responders to SSRIs is augmenta...

Descripción completa

Detalles Bibliográficos
Autores principales: Thamby, Abel, Jaisoorya, T. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343405/
https://www.ncbi.nlm.nih.gov/pubmed/30745677
http://dx.doi.org/10.4103/psychiatry.IndianJPsychiatry_519_18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343405/
https://www.ncbi.nlm.nih.gov/pubmed/30745677
http://dx.doi.org/10.4103/psychiatry.IndianJPsychiatry_519_18

Ejemplares similares